Percutaneous Repair or Surgery for Mitral Regurgitation EVEREST II Objective:to compare the efficacy of percutaneous implantation of a clip and conventional.

Slides:

Advertisements

Similar presentations

Results of the Prospective, Randomized, Multicenter FDA Investigational Device Exemption Study of the ProDisc-L Total Disc Replacement Versus Circumferential.

Advertisements

Percutaneous Therapy of Pulmonic and Mitral Valve Disease Atman P. Shah MD FACC FSCAI Director, Coronary Care Unit Assistant Professor of Medicine The.

Aortic Root Conservative Repair in Acute Type A Aortic Dissection Involving Aortic Root: Fate of Aortic Root & Aortic Valve Function Joon Bum Kim, Su Kyung.

Percutaneous mitral valve repair using the MitraClip® device (e-valve)

FAME 2 year Objective:To investigate the 2-year outcome of PCI guided by FFR in patients with multivessel CAD. Study:Multicenter, single blind, randomized.

Resolute all comers trial Objective:To compare the efficacy and safety of the new generation ZES stent versus the everolimus eluting stent. Study:Multicenter,

STICH Mitral Regurgitation Subanalysis Objective Examine the relationship of mitral regurgitation (MR) severity and survival and compare outcomes in patients.

©2015 MFMER | Robotic Repair of Simple vs. Complex Degenerative Mitral Valve Disease Clinical and Echocardiographic Outcomes During Mid-Term.

Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.

Objective:To assess the effect of various clopidogrel and aspirin regimens on major CV events and ST in ACS patients undergoing PCI. Study:Multicenter,

Stents versus Bypass Surgery for Left Main disease Objective:to assess the non-inferiority of stents compared to bypass surgery for unprotected left main.

Transcatheter versus Surgical Aortic Valve Replacement Objective:to assess the clinical outcomes of transcatheter versus surgical aortic valve replacement.

CABG versus PCI for Lmain/3 V-D: SYNTAX trial 3 year

British Bifurcation Coronary Study Objective:To compare the outcome of 2 treatment strategies for bifurcation lesions. Study:Multicenter, randomized trial.

EVEREST II Study Design Multicenter Randomized in a 2:1 ratio to either percutaneous or conventional surgery for the repair or replacement of the mitral.

Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.

Structural Heart Live Cases

Volume 69, Issue 2, Pages (February 2017)

Division of Cardiovascular Devices

University of Pennsylvania Philadelphia

Washington Hospital Center

Surgical Mitral Valve Repair: What is the Gold Standard?

Surgery for Ebstein’s Anomaly:

Longevity of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk Lars Sondergaard,

Debate - EVEREST and Residual Mitral Regurgitation: Percutaneous Mitral Devices Will Change the Indications for Mitral Valve Procedures Niv Ad, MD Chief,

Axel Linke University of Leipzig Heart Center, Leipzig, Germany

Homograft Replacement of the aortic valve:Ten-year results

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

James Hermiller, MD, FACC, FSCAI St Vincent Hospital, Indianapolis, IN

Cardiovacular Research Technologies

Nishith Patel Waikato Cardiothoracic Unit

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS

Mitral Valve Repair Without Repair of Moderate Tricuspid Regurgitation

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program.

Echocardiographic assessment of mitral durability in the late period following mitral valve repair: Minithoracotomy versus conventional sternotomy Jae.

Surgical Revision After Percutaneous Mitral Repair With the MitraClip Device Michael Argenziano, MD, Eric Skipper, MD, David Heimansohn, MD, George V.

Mitral Valve Disease.

BASKET-PROVE II Trial design: Subjects with stable or unstable coronary artery disease undergoing stent implantation were randomized to a biodegradable-polymer.

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Sildenafil for Improving Outcomes in Patients With Corrected Valvular Heart Disease and Persistent Pulmonary Hypertension: A Multicenter, Double-Blind,

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:

Marc R. Moon, MD The Journal of Thoracic and Cardiovascular Surgery

It is still mostly about the mitral valve

Long-Term Outcomes of the Mosaic Bioprosthesis

EVEREST II randomized clinical trial: Predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure Donald Glower, MD, Gorav.

Patrick T. O'Gara, MD, MACC, FAHA, Thoralf M. Sundt, MD, Michael A

Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines Andrew B.

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines Javier G. Castillo, MD, Anelechi.

Xujun Chen, MD, PhD, Ryan S. Turley, MD, Nicholas D

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial Michael A. Acker, MD,

Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings Sunil K Bhudia, MD, Patrick M McCarthy, MD, Nicholas G Smedira, MD, Buu-Khanh.

Outcome analysis of 245 CarboMedics and St

DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.

Primary safety endpoint

Increased risk of dehiscence after tricuspid valve repair with rigid annuloplasty rings Bettina Pfannmüller, MD, Torsten Doenst, MD, PHD, Katja Eberhardt,

Is repair preferable to replacement for ischemic mitral regurgitation?

Tirone E. David, MD, Carolyn M. David, BN, Cedric Manlhiot, MS

(p for non-inferiority < 0.001)

Mitral valve repair with aortic valve replacement is superior to double valve replacement A.Marc Gillinov, MD, Eugene H Blackstone, MD, Delos M Cosgrove,

Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients Pushpinder Sidhu, Hugh O O’Kane The Annals.

Mitral Repair Versus Replacement for Ischemic Mitral Regurgitation

Valve-sparing aortic root replacement in bicuspid aortic valves: A reasonable option? Diana Aicher, MD, Frank Langer, MD, Anke Kissinger, Henning Lausberg,

Trend of complications for patients undergoing bioprosthetic mitral valve replacement (MVR) for mitral regurgitation between 2003 and Trend of complications.

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Percutaneous Device Occlusion and Minimally Invasive Surgical Repair for Perimembranous Ventricular Septal Defect Zhao Yang Chen, MD, Bing Ru Lin, MD,

Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.

Presentation transcript:

Percutaneous Repair or Surgery for Mitral Regurgitation EVEREST II Objective:to compare the efficacy of percutaneous implantation of a clip and conventional surgery for repair or replacement of the mitral valve Study:multicenter randomized controlled trial (2:1 ratio) Population:patients with grade 3+ or 4+ mitral regurgitation Endpoint:efficacy: freedom from death, surgery for mitral dysf. at 12 months safety: composite of MACE within 30 days Objective:to compare the efficacy of percutaneous implantation of a clip and conventional surgery for repair or replacement of the mitral valve Study:multicenter randomized controlled trial (2:1 ratio) Population:patients with grade 3+ or 4+ mitral regurgitation Endpoint:efficacy: freedom from death, surgery for mitral dysf. at 12 months safety: composite of MACE within 30 days

Percutaneous Repair or Surgery for Mitral Regurgitation EVEREST II

Conclusion percutaneous repair is less effective than surgery for need of surgery for mitral dysfunction, but the safety was superior Conclusion percutaneous repair is less effective than surgery for need of surgery for mitral dysfunction, but the safety was superior Feldman NEJM 2011;364: